Rezultati pretraživanja
  1. Japanese Pulmonary Hypertension Society HP →

  2. new publication: Familial pulmonary arterial hypertension by KDR heterozygous loss of function. .

  3. Interested in ? Take a look at how VOC can help to distinguish patients from controls. Our products offer a potential route for which could improve survival rates & clinical outcomes.

  4. Odgovor korisnicima

    Daughter with . meds are super expensive and it’s a rare genetic disease. is a huge concern. Also continued access to meds under whatever plan is proposed by Dems.

  5. 4. velj

    An excellent new paper utilizing ML and imaging in

  6. 4. velj
    Odgovor korisniku/ci

    Never heard about this! Interesting case, isn't it and others friends?

  7. 4. velj

    announces case study highlighting hemodynamic data that supports the potential of PB1046, a once-weekly VIP analogue for adults with pulmonary arterial hypertension and was presented at the 14th PVRI World Congress.

  8. 4. velj

    Dear All, SAVE THE DATE: Online Webinar - Growing up with PH and the role of parents and family - Tuesday 25 February, 08:00 PST, 16:00 GMT, 17:00 CET <3

    Prikaži ovu nit
  9. can help w/ automatic extraction of arterial hypertension features from cardiac w/ high diagnostic accuracy as Swift et al. showed in their recent work published in

  10. 3. velj

    as a novel negative regulator/transcriptional repressor ID1 & an upstream propagator of a signal converging on and CD47. Insight into the cellular & molecular effects of a functional genetic variant linked to altered outcomes .

  11. 3. velj

    February is . In our next , Benefits of in Cardiology, we'll discuss the clinical significance of DLCO as it relates to & . When? 2/20 @ 2:30PM EST Register today!

  12. 3. velj

    Ke Yuan, Ph.D., received the 2019 PHA Aldrighetti Research Award for Young Investigators for her proposal regarding vascular remodeling in pulmonary arterial hypertension (). Read more about her proposed research here:

  13. 2. velj

    Editorial Board member Dr. Vinicio de Jesus Perez (right; ) with poster presenters at in Lima, Peru. Read some of Dr. de Jesus Perez's work on drug-induced in at &

  14. 31. sij

    Lessons from Cancer: subcellular drug targeting of mitochondrial in pulmonary arterial hypertension

  15. 30. sij

    So much good work from the Robbins' lab showing how iron status can modulate acute responses to hypoxia, however we're still a way off understanding how to manipulate the iron axis for the better in

    Prikaži ovu nit
  16. 30. sij

    Good. Ness. Me. I’ve cut about 60,000 words from that I like - characters from the town that feel so real but they were confusing the main story. Does anyone else get carried away like that? Upside is when Netflix come calling, I’m sorted for content... 🎬📚

  17. Project losing weight is working pretty well. At least for the moment. Only around 6 more kilos to go for a BMI <30.

  18. 30. sij
    Odgovor korisniku/ci

    Looks amazing! Would ❤️ to see some live tweeting of these talks!

  19. 29. sij

    Gotta love Tuesday nights! On Wednesdays, we practice at home... @ North Penn High School

  20. 29. sij

    Sotatercept met the primary and key secondary endpoints of the PULSAR phase 2 trial in patients with , according to the press release

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.